OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment
Yue Yang, Ning Li, Tianming Wang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10827-10827
Open Access | Times Cited: 35
Yue Yang, Ning Li, Tianming Wang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10827-10827
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Naringenin: A potential flavonoid phytochemical for cancer therapy
Mahzad Motallebi, Mohammed Bhia, Huda Fatima Rajani, et al.
Life Sciences (2022) Vol. 305, pp. 120752-120752
Closed Access | Times Cited: 180
Mahzad Motallebi, Mohammed Bhia, Huda Fatima Rajani, et al.
Life Sciences (2022) Vol. 305, pp. 120752-120752
Closed Access | Times Cited: 180
Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation
Muhammad Bilal Ahmed, Salman Ul Islam, Abdullah A. A. Alghamdi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15765-15765
Open Access | Times Cited: 42
Muhammad Bilal Ahmed, Salman Ul Islam, Abdullah A. A. Alghamdi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15765-15765
Open Access | Times Cited: 42
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer
Ting Zhou, Liying Zhang, Jianzheng He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Ting Zhou, Liying Zhang, Jianzheng He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Glycyrrhetinic acid inhibits non-small cell lung cancer via promotion of Prdx6- and caspase-3-mediated mitochondrial apoptosis
Qiuyan Guo, Minghong Zhao, Qixin Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116304-116304
Open Access | Times Cited: 6
Qiuyan Guo, Minghong Zhao, Qixin Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116304-116304
Open Access | Times Cited: 6
β-Elemene induced ferroptosis via TFEB-mediated GPX4 degradation in EGFR wide-type non-small cell lung cancer
Liping Zhao, Haojie Wang, Die Hu, et al.
Journal of Advanced Research (2023) Vol. 62, pp. 257-272
Open Access | Times Cited: 16
Liping Zhao, Haojie Wang, Die Hu, et al.
Journal of Advanced Research (2023) Vol. 62, pp. 257-272
Open Access | Times Cited: 16
Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 15
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 15
Antitumor Effects of Ononin by Modulation of Apoptosis in Non-Small-Cell Lung Cancer through Inhibiting PI3K/Akt/mTOR Pathway
Guowei Gong, Kumar Ganesan, Qingping Xiong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 22
Guowei Gong, Kumar Ganesan, Qingping Xiong, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 22
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing
Thiviyadarshini Rajasegaran, Chee Wun How, Anoosha Saud, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 451-451
Open Access | Times Cited: 13
Thiviyadarshini Rajasegaran, Chee Wun How, Anoosha Saud, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 451-451
Open Access | Times Cited: 13
Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds
Neeraj Choudhary, Sweta Bawari, Jack T. Burcher, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3980-3980
Open Access | Times Cited: 13
Neeraj Choudhary, Sweta Bawari, Jack T. Burcher, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3980-3980
Open Access | Times Cited: 13
Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism
Wangqi Tian, Jumin Huang, Weitong Zhang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107034-107034
Open Access | Times Cited: 10
Wangqi Tian, Jumin Huang, Weitong Zhang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107034-107034
Open Access | Times Cited: 10
Targeting the prostate tumor microenvironment by plant-derived natural products
Jiacheng Wu, Hao Ji, Tiantian Li, et al.
Cellular Signalling (2023) Vol. 115, pp. 111011-111011
Closed Access | Times Cited: 10
Jiacheng Wu, Hao Ji, Tiantian Li, et al.
Cellular Signalling (2023) Vol. 115, pp. 111011-111011
Closed Access | Times Cited: 10
Antifungal Carvacrol Loaded Chitosan Nanoparticles
Alberto Vitali, Annarita Stringaro, Marisa Colone, et al.
Antibiotics (2021) Vol. 11, Iss. 1, pp. 11-11
Open Access | Times Cited: 24
Alberto Vitali, Annarita Stringaro, Marisa Colone, et al.
Antibiotics (2021) Vol. 11, Iss. 1, pp. 11-11
Open Access | Times Cited: 24
Efficacy and Mechanisms of Natural Products as Therapeutic Interventions for Chronic Respiratory Diseases
Fanli Jin, Pengbei Fan, Yuanyuan Wu, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 01, pp. 57-88
Closed Access | Times Cited: 2
Fanli Jin, Pengbei Fan, Yuanyuan Wu, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 01, pp. 57-88
Closed Access | Times Cited: 2
Natural Bacterial and Fungal Peptides as a Promising Treatment to Defeat Lung Cancer Cells
Kamila Rybczyńska‐Tkaczyk, Anna Grenda, Anna Jakubczyk, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4381-4381
Open Access | Times Cited: 5
Kamila Rybczyńska‐Tkaczyk, Anna Grenda, Anna Jakubczyk, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4381-4381
Open Access | Times Cited: 5
High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
Bodong Zhou, Wenbo Zhu, Shuai Yuan, et al.
Thoracic Cancer (2021) Vol. 13, Iss. 3, pp. 369-379
Open Access | Times Cited: 14
Bodong Zhou, Wenbo Zhu, Shuai Yuan, et al.
Thoracic Cancer (2021) Vol. 13, Iss. 3, pp. 369-379
Open Access | Times Cited: 14
Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancer
Rasha Irshad, Nafis Raj, Gamal A. Gabr, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Rasha Irshad, Nafis Raj, Gamal A. Gabr, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer
Ling Xu, Peng Cao, Jianpeng Wang, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e35901-e35901
Open Access | Times Cited: 1
Ling Xu, Peng Cao, Jianpeng Wang, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e35901-e35901
Open Access | Times Cited: 1
Unveiling the mechanism of sericin and hydroxychloroquine in suppressing lung oxidative impairment and early carcinogenesis in diethylnitrosamine-induced mice by modulating PI3K/Akt/Nrf2/NF-κB signaling pathway
Lamia M. El‐Samad, Alaa M Maklad, Ayman I. Elkady, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117730-117730
Open Access | Times Cited: 1
Lamia M. El‐Samad, Alaa M Maklad, Ayman I. Elkady, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117730-117730
Open Access | Times Cited: 1
Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way
Priyanka Upadhyay, Avijit Ghosh, Vijaya Sarangthem, et al.
Phytochemistry Reviews (2023) Vol. 23, Iss. 2, pp. 485-527
Closed Access | Times Cited: 4
Priyanka Upadhyay, Avijit Ghosh, Vijaya Sarangthem, et al.
Phytochemistry Reviews (2023) Vol. 23, Iss. 2, pp. 485-527
Closed Access | Times Cited: 4
Menthol induces apoptosis and inhibits proliferation and migration of nonsmall cell lung carcinoma in vitro and in vivo through Akt pathway
Zhiyu Liu, Chunlin Li, Mu Ling, et al.
The Clinical Respiratory Journal (2023) Vol. 17, Iss. 12, pp. 1265-1275
Open Access | Times Cited: 4
Zhiyu Liu, Chunlin Li, Mu Ling, et al.
The Clinical Respiratory Journal (2023) Vol. 17, Iss. 12, pp. 1265-1275
Open Access | Times Cited: 4
Artonin F Induces the Ubiquitin-Proteasomal Degradation of c-Met and Decreases Akt-mTOR Signaling
Rapeepun Soonnarong, Ismail Dwi Putra, Nicharat Sriratanasak, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 633-633
Open Access | Times Cited: 6
Rapeepun Soonnarong, Ismail Dwi Putra, Nicharat Sriratanasak, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 633-633
Open Access | Times Cited: 6
Immunoradiotherapy for NSCLC: mechanisms, clinical outcomes, and future directions
He Weishan, Zheng Dong-lin, Deng Guangmei, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 5, pp. 1063-1076
Open Access | Times Cited: 2
He Weishan, Zheng Dong-lin, Deng Guangmei, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 5, pp. 1063-1076
Open Access | Times Cited: 2
Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
Jiaqi Hu, Juling Jiang, Rui Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Jiaqi Hu, Juling Jiang, Rui Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Celastrol Inhibited Human Esophageal Cancer by Activating DR5-Dependent Extrinsic and Noxa/Bim-Dependent Intrinsic Apoptosis
Xihui Chen, Shiwen Wang, Li Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Xihui Chen, Shiwen Wang, Li Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4